Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 729 JPY 0.26% Market Closed
Market Cap: 425.9B JPY
Have any thoughts about
Kobayashi Pharmaceutical Co Ltd?
Write Note

Kobayashi Pharmaceutical Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kobayashi Pharmaceutical Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Additional Paid In Capital
ÂĄ522m
CAGR 3-Years
-50%
CAGR 5-Years
-34%
CAGR 10-Years
-19%
Shiseido Co Ltd
TSE:4911
Additional Paid In Capital
ÂĄ73.7B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
0%
Rohto Pharmaceutical Co Ltd
TSE:4527
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kao Corp
TSE:4452
Additional Paid In Capital
ÂĄ106.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Kose Corp
TSE:4922
Additional Paid In Capital
ÂĄ179m
CAGR 3-Years
N/A
CAGR 5-Years
64%
CAGR 10-Years
-30%
F
Fancl Corp
TSE:4921
Additional Paid In Capital
ÂĄ12.2B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
0%
No Stocks Found

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
425.9B JPY
Industry
Consumer products

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. The company is headquartered in Osaka, Osaka-Fu and currently employs 3,451 full-time employees. The firm operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.

Intrinsic Value
6 884.48 JPY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Kobayashi Pharmaceutical Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
522m JPY

Based on the financial report for Jun 30, 2024, Kobayashi Pharmaceutical Co Ltd's Additional Paid In Capital amounts to 522m JPY.

What is Kobayashi Pharmaceutical Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
-19%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Kobayashi Pharmaceutical Co Ltd have been -50% over the past three years , -34% over the past five years , and -19% over the past ten years .

Back to Top